How We Can Help

Update your billing and coding systems to include the permanent CYRAMZA® (ramucirumab) J-code: J9308, injection, ramucirumab, 5 mg. Issued by the Centers for Medicare & Medicaid Services (CMS), this permanent J-code is effective as of January 1, 2016.

How We Can Help

Find out how our personalized services could help you.

It's important to know you're not alone as you begin your treatment journey. Through Lilly PatientOne, you and your doctor may find resources to help you navigate the complex and often confusing world of coverage and reimbursement. We offer a range of services for your individual situation, even if you're not insured. So you can start treatment with one less worry.

Lilly PatientOne offers: If you are prescribed a Lilly Oncology drug, qualify* for assistance, and are:
Insured Underinsured Uninsured
Benefits investigation to help your doctor verify your coverage and determine your out-of-pocket costs (if any) Checkmark Checkmark
Resources to help your doctor's office submit a prior authorization Checkmark Checkmark
Resources for denied claims and appeals Checkmark Checkmark
Status updates for appeals at your doctor's request Checkmark Checkmark
Drug-specific co-pay programs for eligible patients Checkmark Checkmark
Information on charitable foundations and referrals at your doctor's request Checkmark Checkmark
Collects information on behalf of the Lilly Cares Foundation Checkmark Checkmark Checkmark

Reimbursement programs for Lilly Oncology products are administered by an independent pharmaceutical services company in consultation with Lilly USA, LLC. These programs are available to members of the medical profession and/or patients prescribed an eligible Lilly Oncology product by request. Neither Lilly USA, LLC, nor the pharmaceutical services company guarantees insurance reimbursement, nor will either entity be responsible for filing any insurance claim. It is the responsibility of the patient and/or the patient’s physician to obtain all patient consents required for release of personal health information to the pharmaceutical services company. Lilly reserves the right to discontinue or modify reimbursement programs for Lilly Oncology products at any time, without notice.

* Qualifications may vary depending on your circumstances.